Deregulation of glutamate dehydrogenase in human neurologic disorders

Journal of Neuroscience Research

Volumn 91, Issue 8, 2013, Pages 1007-1017

  Plaitakis, Andreas ^a   Zaganas, Ioannis ^a   Spanaki, Cleanthe ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Dystonia; GLUD1 and GLUD2 deregulation; Parkinson's disease

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA SYNUCLEIN; ESTROGEN; GLUTAMATE DEHYDROGENASE; GLUTAMATE SYNTHASE (NADH); GUANOSINE TRIPHOSPHATE; HALOPERIDOL; NEUROLEPTIC AGENT; SPERMIDINE;

CATALYSIS; CELL DEGENERATION; DIET RESTRICTION; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME PURIFICATION; ENZYME REGULATION; ENZYME STRUCTURE; EXCITOTOXICITY; GAIN OF FUNCTION MUTATION; GENE INTERACTION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HIPPOCAMPUS; HUMAN; HYPERAMMONEMIA; HYPOGLYCEMIA; NERVE CELL; NEUROLOGIC DISEASE; NONHUMAN; ONSET AGE; PARKINSON DISEASE; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SCHIZOPHRENIA; UPREGULATION;

ANIMALS; FEMALE; GLUTAMATE DEHYDROGENASE; HUMANS; MALE; MUTATION; NERVOUS SYSTEM DISEASES; SEX FACTORS;

EID: 84879604039     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23176     Document Type: Review

References (75)

1. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, Nicotera P. 1995. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15:961-973.
2. Aoki C, Milner T, Berger S, Sheu K, Blass J, Pickel V. 1987. Glial glutamate dehydrogenase: ultrastructural localization and regional distribution in relation to the mitochondrial enzyme, cytochrome oxidase. JNeurosci Res 18:305-318.
3. Arundine M, Tymianski M. 2004. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci 61:657-668.
4. Bahi-Buisson N, Roze E, Dionisi C, Escande F, Valayannopoulos V, Feillet F, Heinrichs C, Chadefaux-Vekemans B, Dan B, de Lonlay P. 2008. Neurological aspects of hyperinsulinism-hyperammonaemia syndrome. Dev Med Child Neurol 50:945-949.
5. Bao X, Pal R, Hascup KN, Wang Y, Wang WT, Xu W, Hui D, Agbas A, Wang X, Michaelis ML, Choi IY, Belousov AB, Gerhardt GA, Michaelis EK. 2009. Transgenic expression of Glud1 (glutamate dehydrogenase 1) in neurons: in vivo model of enhanced glutamate release, altered synaptic plasticity, and selective neuronal vulnerability. J Neurosci 29:13929-13944.
6. Banerjee S, Schmidt T, Fang J, Stanley CA, Smith TJ. 2003. Structural studies on ADP activation of mammalian glutamate dehydrogenase and the evolution of regulation. Biochemistry 42:3446-3456.
7. Bartha R, Williamson PC, Drost DJ, Malla A, Carr TJ, Cortese L, Canaran G, Rylett RJ, Neufeld RW. 1997. Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 54:959-965.
8. Berthiaume L, Deichaite I, Peseckis S, Resh MD. 1994. Regulation of enzymatic activity by active site fatty acylation. A new role for long chain fatty acid acylation of proteins. J Biol Chem 4269:6498-6505.
9. Borompokas N, Papachatzaki MM, Kanavouras K, Mastorodemos V, Zaganas I, Spanaki C, Plaitakis A. 2010. Estrogen modification of human glutamate dehydrogenases is linked to enzyme activation state. JBiol Chem 285:31380-31387.
10. Burbaeva GS, Boksha IS, Turishcheva MS, Vorobyeva EA, Savushkina OK, Tereshkina EB. 2003. Glutamine synthetase and glutamate dehydrogenase in the prefrontal cortex of patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 27:675-680.
11. Burbaeva GS, Boksha IS, Tereshkina EB, Savushkina OK, Starodubtseva LI, Turishcheva MS, Mukaetova-Ladinska E. 2007. Systemic neurochemical alterations in schizophrenic brain: glutamate metabolism in focus. Neurochem Res 32:1434-1444.
12. Burki F, Kaessmann H. 2004. Birth and adaptive evolution of a hominoid gene that supports high neurotransmitter flux. Nat Genet 36:1061-1063.
13. Carlsson A, Carlsson ML. 2006. A dopaminergic deficit hypothesis of schizophrenia: the path to discovery. Dialogues Clin Neurosci 8:137-142.
14. Cavallaro S, Meiri N, Yi CL, Musco S, Ma W, Goldberg J, Alkon DL. 1997. Late memory-related genes in the hippocampus revealed by RNA fingerprinting. Proc Natl Acad Sci U S A 94:9669-9673.
15. Contestabile A, Andersen H. 1978. Methodological aspects of the histochemical localization and activity of some cerebellar dehydrogenases. Histochemistry 56:117-132.
16. Couée I, Tipton KF. 1990. The inhibition of glutamate dehydrogenase by some antipsychotic drugs. Biochem Pharmacol 39:827-832.
17. Erecinska M, Nelson D. 1990. Activation of glutamate dehydrogenase by leucine and its nonmetabolizable analogue in rat brain synaptosomes. J Neurochem 54:1335-1343.
18. Fahien LA, Kiomtek E. 1981. Regulation of glutamate dehydrogenase by palmitoyl-coenzyme A. Arch Biochem Biophys 212:247-253.
19. Fahien LA, Macdonald MJ. 2011. The complex mechanism of glutamate dehydrogenase in insulin secretion. Diabetes 60:2450-2454.
20. Fahien LA, Shemisa O. 1970. Effects of chlorpromazine on glutamate dehydrogenase. Mol Pharmacol 6:156-163.
21. Fang J, Hsu BY, MacMullen CM, Poncz M, Smith TJ, Stanley CA. 2002Expression, purification and characterization of human glutamate dehydrogenase (GDH) allosteric regulatory mutations. Biochem J 363:81-87.
22. Gluck MR, Thomas RG, Davis KL, Haroutunian V. 2002. Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients. Am J Psychiatry 159:1165-1173.
23. Haigis MC, Mostoslavsky R, Haigis KM, Fahie K, Christodoulou DC, Murphy AJ, Valenzuela DM, Yancopoulos GD, Karow M, Blander G, Wolberger C, Prolla TA, Weindruch R, Alt FW, Guarente L. 2006. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 126:941-954.
24. Halberstadt AL. 1995. The phencyclidine-glutamate model of schizophrenia. Clin Neuropharmacol 18:237-249.
25. Hashimoto K, Engberg G, Shimizu E, Nordin C, Lindström LH, Iyo M. 2005. Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients. BMC Psychiatry 5:6.
26. Jarzyna R, Lietz T, Brya J. 1994. Effect of polyamines on glutamate dehydrogenase within permeabilized kidney-cortex mitochondria and isolated renal tubules of rabbit. Biochem Pharmacol 47:1387-1393.
27. Kanavouras K, Borompokas N, Latsoudis H, Stagourakis A, Zaganas I, Plaitakis A. 2009. Mutations in human GLUD2 glutamate dehydrogenase affecting basal activity and regulation. J Neurochem 109( Suppl 1):167-173.
28. Komuro H, Rakic P. 1993. Modulation of neuronal migration by NMDA receptors. Science 260:95-97.
29. Krystal JH, D'souza DC, Petrakis IL, Belger A, Berman RM, Charney DS, Abi-Saab W, Madonick S. 1999. NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders. Harv Rev Psychiatry 7:125-143.
30. 2+ and polyamines: a possible cause for its low in vivo activity. J Neurochem 63:751-757.
31. Levy LM, Hallett M. 2002. Impaired brain GABA in focal dystonia. Ann Neurol 51:93-101.
32. Li C, Chen P, Palladino A, Narayan S, Russell LK, Sayed S, Xiong G, Chen J, Stokes D, Butt YM, Jones PM, Collins HW, Cohen NA, Cohen AS, Nissim I, Smith TJ, Strauss AW, Matschinsky FM, Bennett MJ, Stanley CA. 2010. Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency involves activation of glutamate dehydrogenase. J Biol Chem 285:31806-31818.
33. Li M, Li C, Allen A, Stanley CA, Smith TJ. 2011. The structure and allosteric regulation of glutamate dehydrogenase. Neurochem Int 59:445-455.
34. Luengo de Borges E, Ryder E, Campos G. 1982. Lack of effect on glutamate dehydrogenase activity after in vivo administration of pharmacological doses of haloperidol. Biochem Pharmacol 31:1446-1448.
35. Masliah E, Mallory M, Hansen L, DeTeresa R, Terry RD. 1993. Quantitative synaptic alterations in the human neocortex during normal aging. Neurology 43:192-197.
36. McEntee WJ, Crook TH. 1993. Glutamate: its role in learning, memory, and the aging brain. Psychopharmacology 111:391-401.
37. McKenna MC. 2011. Glutamate dehydrogenase in brain mitochondria: do lipid modifications and transient metabolon formation influence enzyme activity?Neurochem Int 59:525-533.
38. McKenna M, Tildon J, Stevenson J, Huang X. 1996. New insights into the compartmentation of glutamate and glutamine in cultured rat brain astrocytes. Dev Neurosci 18:380-390.
39. Michaelis EK. 1998. Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog Neurobiol 54:369-415.
40. Miyamoto R, Goto S, Sako W, Miyashiro A, Kim I, Escande F, Harada M, Morigaki R, Asanuma K, Mizobuchi Y, Nagahiro S, Izumi Y, Kaji R. 2012. Generalized dystonia in a patient with a novel mutation in the GLUD1 gene. Mov Disord doi: 10.1002/mds.25081.
41. Molven A, Matre GE, Duran M, Wanders RJ, Rishaug U, Njlstad PR, Jellum E, Svik O. 2004. Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation. Diabetes 53:221-227.
42. Morrison JH, Hof PR. 1997. Life and death of neurons in the aging brain. Science 278:412-419.
43. Palaiologos G, Hertz L, Schousboe A. 1989. Role of aspartate aminotransferase and mitochondrial dicarboxylate transport for release of endogenously and exogenously supplied neurotrasmitter in glutamatergic neurons. Neurochem Res 14:359-366.
44. Peterson PE, Smith TJ. 1999. The structure of bovine glutamate dehydrogenase provides insights into the mechanism of allostery. Structure 7:769-782.
45. Place GA, Beynon RJ. 1982. The chymotrypsin-catalysed activation of bovine liver glutamate dehydrogenase. Biochem J 205:75-80.
46. Plaitakis A, Berl S, Yahr MD. 1982. Abnormal glutamate metabolism in an adult onset degenerative neurological disorder. Science 216:193-196.
47. Plaitakis A, Berl S, Yahr M. 1984. Neurological disorders associated with deficiency of glutamate dehydrogenase. Ann Neurol 15:144-153.
48. Plaitakis A, Latsoudis H, Kanavouras K, Ritz B, Bronstein JM, Skoula I, Mastorodemos V, Papapetropoulos S, Borompokas N, Zaganas I, Xiromerisiou G, Hadjigeorgiou GM, Spanaki C. 2010. Gain-of-function variant in GLUD2 glutamate dehydrogenase modifies Parkinson's disease onset. Eur J Hum Genet 18:336-341.
49. Plaitakis A, Latsoudis H, Spanaki C. 2011. The human GLUD2 glutamate dehydrogenase and its regulation in health and disease. Neurochem Int 59:495-509.
50. Raizen DM, Brooks-Kayal A, Steinkrauss L, Tennekoon GI, Stanley CA, Kelly A. 2005. Central nervous system hyperexcitability associated with glutamate dehydrogenase gain of function mutations. J. Pediatr 146:388-394.
51. Schousboe A, Madsen KK, White HS. 2011. GABA transport inhibitors and seizure protection: the past and future. Future Med Chem 3:183-187.
52. Schwarcz R, Meldrum B. 1985. Excitatory aminoacid antagonists provide a therapeutic approach to neurological disorders. Lancet 2:140-143.
53. Seiler N, Deckardt K. 1978. Association of putrescine, spermidine, spermine andGABA with structural elements of brain cells. Neurochem Res 1:161-167.
54. Shashidharan P, Michaelidis TM, Robakis NK, Kresovali A, Papamattheakis J, Plaitakis A. 1994. Novel human glutamate dehydrogenase expressed in neural and testicular tissues and encoded by an X-linked intronless gene. J Biol Chem 269:16971-16976.
55. Shashidharan P, Clarke DD, Ahmed N, Moschonas N, Plaitakis A. 1997. Nerve tissue-specific human glutamate dehydrogenase that is thermolabile and highly regulated by ADP. J Neurochem 68:1804-1811.
56. Shemisa OA, Fahien LA. 1971. Modifications of glutamate dehydrogenase by various drugs which affect behavior. Mol Pharmacol 7:8-25.
57. Shen J. 2005. In vivo carbon-13 magnetization transfer effect. Detection of aspartate amitransferase reaction. Magn Reson Med 54:1321-1326.
58. Smith T, Stanley C. 2008. Untangling the glutamate dehydrogenase allosteric nightmare. Trends Biochem Sci 33:557-564.
59. Smith TJ, Schmidt T, Fang J, Wu J, Siuzdak G, Stanley CA. 2002. The structure of apo human glutamate dehydrogenase details subunit communication and allostery. J Mol Biol 318:765-777.
60. Sonnewald U, Westergaard N, Schousboe A. 1997. Glutamate transport and metabolism in astrocytes. Glia 21:56-63.
61. Spanaki C, Plaitakis A. 2012. The role of glutamate dehydorgenase in mammalian ammonia metabolism. Neurotox Res 21:117-127.
62. Spanaki C, Zaganas I, Kleopas K, Plaitakis A. 2010. Human GLUD2 glutamate dehydrogenase is expressed in neural and testicular supportive cells. J Biol Chem 285:16748-16756.
63. Spanaki C, Zaganas I, Kounoupa Z, Plaitakis A. 2012. The complex regulation of human glud1 and glud2 glutamate dehydrogenases and its implications in nerve tissue biology. Neurochem Int (in press).
64. Stanley CA. 2011. Two genetic forms of hyperinsulinemic hypoglycemia caused by dysregulation of glutamate dehydrogenase. Neurochem Int 59:465-472.
65. Stanley CA, Lieu YK, Hsu BYL, Burlina AB, Greenberg CR, Hopwood NJ, Perlman K, Rich BH, Zammarchi E, Poncz M. 1998. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med 338:1352-1357.
66. Tamminga CA, Frost DO. 2001. Changing concepts in the neurochemistry of schizophrenia. Am J Psychiatry 158:1365-1366.
67. Terry RD, DeTeresa R, Hansen LA. 1987. Neocortical cell counts in normal human adult aging. Ann Neurol 21:530-539.
68. Théberge J, Al-Semaan Y, Williamson PC, Menon RS, Neufeld RW, Rajakumar N, Schaefer B, Densmore M, Drost DJ. 2003. Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. Am J Psychiatry 160:2231-2233.
69. Treberg JR, Clow KA, Greene KA, Brosnan ME, Brosnan JT. 2010. Systemic activation of glutamate dehydrogenase increases renal ammoniagenesis: implications for the hyperinsulinism/hyperammonemia syndrome. Am J Physiol Endocrinol Metab 298:E1219-E1225.
70. Tsai G, Passani LA, Slusher BS, Carter R, Baer L, Kleinman JE, Coyle JT. 1995. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 52:829-836.
71. Wang X, Bao X, Pal R, Agbas A, Michaelis EK. 2010. Transcriptomic responses in mouse brain exposed to chronic excess of the neurotransmitter glutamate. BMC Genomics 11:360.
72. Zaganas I, Plaitakis A. 2002. Single amino acid substitution (G456A) in the vicinity of the GTP binding domain of human housekeeping glutamate dehydrogenase markedly attenuates GTP inhibition and abolishes the cooperative behavior of the enzyme. J Biol Chem 277:26422-26428.
73. Zaganas I, Waagepetersen HS, Georgopoulos P, Sonnewald U, Plaitakis A, Schousboe A. 2001. Differential expression of glutamate dehydrogenase in cultured neurons and astrocytes from mouse cerebellum and cerebral cortex. J Neurosci Res 66:909-913.
74. Zaganas I, Spanaki C, Karpusas M, Plaitakis A. 2002. Substitution of Ser for Arg-443 in the regulatory domain of human housekeeping (GLUD1) glutamate dehydrogenase virtually abolishes basal activity and markedly alters the activation of the enzyme by ADP and L-leucine. JBiol Chem 277:46552-46558.
75. Zaganas I, Spanaki C, Plaitakis A. 2012. Expression of human GLUD2 glutamate dehydrogenase in human tissues: functional implications. Neurochem Int (in press).